Omapatrilat is an antihypertensive agent that inhibits both neutral endopeptidase (NEP) and angiotensin converting enzyme.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Omapatrilat was originally identified as a selective dual inhibitor of angiotensin-converting enzyme (ACE) and neprilysin (NEP). The K values of omapatrilat against NEP, NEP2, endothelin-converting enzyme 1 (ECE1), ACE, and aminopeptidase P (APP) were 0.00045, 0.025, 10, 0.00064, and 0.25μM, respectively. In Sprague–Dawley rats subjected to an optimal dose of bradykinin (100ng/min), omapatrilat (0.0, 0.53, 1.76, or 5.3mg/kg) resulted in a dose-dependent reduction in the mean arterial blood pressure area under the curve (MAP AUC). Peak reduction was observed in the group administered with 1.76 and 5.3mg/kg omapatrilat. The effect of omapatrilat on MAP AUC was reduced when the doses of bradykinin decreased (10 and 30ng/min). Rats administered with omapatrilat at doses of 1.76 and 5.3mg/kg exhibited blunted reflex tachycardia.[1] |
作用机制 | Omapatrilat exhibits potent inhibitory activity against three bradykinin-metabolizing enzymes: NEP, ACE, and APP. The concomitant inhibition of both APP and ACE by omapatrilat is probably the primary mechanism responsible for the large depressor response in rats and angioedema in patients.[1] |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.45mL 0.49mL 0.24mL |
12.24mL 2.45mL 1.22mL |
24.48mL 4.90mL 2.45mL |
CAS号 | 167305-00-2 |
分子式 | C19H24N2O4S2 |
分子量 | 408.535 |
别名 | BMS-186716 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,2-8°C |
溶解方案 |
DMSO: 30 mg/mL(73.43 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |